National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Department of Pharmaceutical Sciences, College of Pharmacy, The University of Illinois at Chicago, Chicago, IL 60612, USA.
Molecules. 2022 Dec 12;27(24):8811. doi: 10.3390/molecules27248811.
A novel macrolactam named oxalactam A (), three known dipeptides (-) as well as other known alkaloids (-) were obtained from the endophytic fungus , which was derived from the tuber of (Icacinaceae). All chemical structures were established based on spectroscopic data, chemical methods, ECD calculations, and C-DP4+ analysis. Among them, oxalactam A () is a 16-membered polyenic macrolactam bearing a new skeleton of 2,9-dimethyl-azacyclohexadecane core and exhibited potent anti- activity with a MIC value of 10 μg/mL in vitro. The plausible biosynthetic pathway of was also proposed via the alanyl protecting mechanism. Notably, three dipeptides (-) were first identified from the endophytic fungus and the NMR data of cyclo(-Trp--Glu) () was reported for the first time. In addition, the binding interactions between compound and the sterol 14-demethylase enzyme (CYP51) were studied by molecular docking and dynamics technologies, and the results revealed that the 16-membered polyenic macrolactam could be a promising CYP51 inhibitor to develop as a new anti- fungicide.
从 (Icacinaceae)的块茎中内生真菌 中分离得到一种新型大环内酯类化合物 oxalactam A (),三种已知二肽 (-) 以及其他已知生物碱 (-)。所有化学结构均基于光谱数据、化学方法、ECD 计算和 C-DP4+分析确定。其中,oxalactam A () 是一种含有 2,9-二甲基-氮杂环十六烷核心的新型骨架的 16 元聚烯大环内酯,具有很强的抗活性,体外 MIC 值为 10 μg/mL。还通过丙氨酰保护机制提出了 的可能生物合成途径。值得注意的是,三种二肽 (-) 首次从内生真菌 中鉴定出来,并且首次报道了环 (-Trp--Glu) () 的 NMR 数据。此外,通过分子对接和动力学技术研究了化合物 与甾醇 14-去甲基酶(CYP51)之间的结合相互作用,结果表明,16 元聚烯大环内酯类化合物可能是一种很有前途的 CYP51 抑制剂,可开发为新型抗真菌剂。